Clinical Trials for Rituximab (Rituxan)

3 Open Trials

Trial TypeProtocol No. &
Open Date
Summary
TreatmentVICCHEM12103
12/31/2013
Multi-center Phase II Study to Establish Gene Expression Models Predicting Survival of Diffuse Large B-Cell Lymphoma Patients Treated With R-Chop
TreatmentVICCBMT1148
05/11/2012
A Randomized Phase II Study of Imatinib and Rituximab for Cutaneous Sclerosis after Allogeneic Hematopoietic Cell Transplantation (Consortium)
TreatmentECOGHEME2408
05/10/2011
A 3-Arm Randomized Phase II Trial of Bendamustine-Rituximab (BR) Followed by Rituximab vs Bortezomib-BR (BVR) Followed by Rituximab vs BR Follwed by Lenalidomide/Rituximab in High Risk Follicular Lymphoma

Back to Find By Drug

You do not have JavaScript enabled. This site works better with JavaScript turned on.